AR059121A1 - IMMUNE RESPONSE MODIFIER PREPARATIONS CONTAINING OLEIC ACID AND METHODS - Google Patents

IMMUNE RESPONSE MODIFIER PREPARATIONS CONTAINING OLEIC ACID AND METHODS

Info

Publication number
AR059121A1
AR059121A1 ARP070100012A AR059121A1 AR 059121 A1 AR059121 A1 AR 059121A1 AR P070100012 A ARP070100012 A AR P070100012A AR 059121 A1 AR059121 A1 AR 059121A1
Authority
AR
Argentina
Prior art keywords
amines
oleic acid
preparation
immune response
response modifier
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Alexis S Statham
Robert J Nelson
Original Assignee
Graceway Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Graceway Pharmaceuticals Llc filed Critical Graceway Pharmaceuticals Llc
Priority to ARP070100012 priority Critical patent/AR059121A1/en
Publication of AR059121A1 publication Critical patent/AR059121A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Preparaciones farmacéuticas y métodos que incluyen un compuesto de modificador de respuesta inmune (MRI) y un componente de ácido oleico, donde se mejora la estabilidad utilizando ácido oleico con baja cantidad de impurezas polares, como por ejemplo los peroxidos. Reivindicacion 1: Una preparacion farmacéutica que consiste en: Una cantidad terapéuticamente efectiva de un compuesto de modificador de respuesta inmune (MRI) seleccionado del grupo que consiste en imidazoquinolina aminas, tetrahidroimidazoquinolina aminas, imidazopiridina aminas, cicloalquilimidazopiridina aminas fusionadas 6,7, 1,2- imidazoquinolina aminas pueste, imidazonaftiridina aminas, tetrahidroimidazonaftiridina aminas, oxazoloquinolina aminas, tiazoloquinolina aminas, oxazolopiridina aminas, tiazolopiridina aminas, oxazolonaftiridina aminas, tiazolonaftiridina aminas, 1H- imidazo dimeros fusionados a piridina aminas, quinolina aminas, tetrahidroquinolina aminas, naftiridina aminas o tetrahidronaftiridina aminas y una combinacion de éstos y; un vehículo aceptable desde el punto de vista farmacéutico que incluye un componente de ácido oleico donde la preparacion está substancialmente libre de las impurezas polares que introduce el componente de ácido oleico. Reivindicacion 25: Un método para tratar la queratosis actínica, que consiste en aplicar la preparacion de la reivindicacion 1 sobre la piel del paciente. Reivindicacion 28: Un método para inducir la biosíntesis de la interferona, que consiste en aplicar la preparacion de la reivindicacion 1 sobre la piel o superficie de la mucosa del paciente.Pharmaceutical preparations and methods that include an immune response modifier compound (MRI) and an oleic acid component, where stability is improved using oleic acid with low amount of polar impurities, such as peroxides. Claim 1: A pharmaceutical preparation consisting of: A therapeutically effective amount of an immune response modifier (MRI) compound selected from the group consisting of imidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridine amines, fused cycloalkylimidazopyridine amines 6.7, 1.2 - imidazoquinoline amines pueste, imidazonaphthyridine amines, tetrahidroimidazonaftiridina amines, oxazoloquinolina, tiazoloquinolina amines, oxazolopyridine amines, thiazolopyridine amines, oxazolonaftiridina amines, tiazolonaftiridina, 1H- imidazo dimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines, naphthyridine amines, or tetrahydronaphthyridine amines and a combination of these and; a pharmaceutically acceptable vehicle that includes an oleic acid component where the preparation is substantially free of the polar impurities introduced by the oleic acid component. Claim 25: A method of treating actinic keratosis, which consists in applying the preparation of claim 1 on the patient's skin. Claim 28: A method of inducing the biosynthesis of interferon, which consists in applying the preparation of claim 1 on the skin or surface of the patient's mucosa.

ARP070100012 2007-01-02 2007-01-02 IMMUNE RESPONSE MODIFIER PREPARATIONS CONTAINING OLEIC ACID AND METHODS AR059121A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP070100012 AR059121A1 (en) 2007-01-02 2007-01-02 IMMUNE RESPONSE MODIFIER PREPARATIONS CONTAINING OLEIC ACID AND METHODS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP070100012 AR059121A1 (en) 2007-01-02 2007-01-02 IMMUNE RESPONSE MODIFIER PREPARATIONS CONTAINING OLEIC ACID AND METHODS

Publications (1)

Publication Number Publication Date
AR059121A1 true AR059121A1 (en) 2008-03-12

Family

ID=39186224

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070100012 AR059121A1 (en) 2007-01-02 2007-01-02 IMMUNE RESPONSE MODIFIER PREPARATIONS CONTAINING OLEIC ACID AND METHODS

Country Status (1)

Country Link
AR (1) AR059121A1 (en)

Similar Documents

Publication Publication Date Title
PL349773A1 (en) Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions
WO2005016275A3 (en) Formulations containing an immune response modifier
US7902216B2 (en) Pharmaceutical creams with refined oleic acid
DK1450804T3 (en) Pharmaceutical formula rings comprising an immune response modifier
EA201890852A1 (en) VALBENASIN SALTS AND THEIR POLYMORPHES
AR044922A1 (en) IMIDAZOQUINOLINAS REPLACED WITH SULFONAMIDE
BR112013003772A2 (en) lipid immune response modifying compound compositions, formulations and methods
SMT201300095B (en) Use of the ethyl ester of eicosapentaenoic acid to treat hypertriglyceridemia
PE20100469A1 (en) IMIQUIMOD FORMULATIONS
EP1495758A3 (en) Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
EA201490544A1 (en) PREPARATIONS AND MEDICATION FORMS BASED ON OXIDIZED PHOSPHOLIPIDS
UY31588A1 (en) IMIDAZO DERIVATIVES [1,2-A] PIRIDIN-2-CARBOXAMIDS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
AR059121A1 (en) IMMUNE RESPONSE MODIFIER PREPARATIONS CONTAINING OLEIC ACID AND METHODS
CA2643679C (en) Immune response modifier formulations containing oleic acid and methods
WO2011137876A3 (en) Adjuvanted tolerogens as a malaria vaccine
UY31591A1 (en) DERIVATIVES OF 2-BENZOIL-IMIDAZO [1,2-A] PIRIDINE, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS

Legal Events

Date Code Title Description
FB Suspension of granting procedure